Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ai Kido

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 9, 2021
Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims databaseAi Kido, Masahiro Miyake, Tadamichi Akagi, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 9, 2025
One-year outcomes of three-monthly and four-monthly loading regimens of faricimab for treatment-naïve neovascular age-related macular degenerationYuta Doi, Masayuki Hata, Yu Kawashima, et al.
Ophthalmology Science|October 17, 2022
Incidence and Clinical Practice of Exudative Age-related Macular Degeneration: A Nationwide Population-Based Cohort StudyAi Kido, Masahiro Miyake, Hiroshi Tamura, et al.
Ophthalmology Science|April 4, 2025
Annual Trend of Myopia and High Myopia in Children in Japan: A Nationwide Claims Database StudyTakuro Kamei, Masahiro Miyake, Ai Kido, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 26, 2024
Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular DegenerationAsako Tanaka, Masayuki Hata, Memiri Tsuchikawa, et al.
Retina (Philadelphia, Pa.)|July 25, 2023
PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGEMakoto Miki, Manabu Miyata, Sotaro Ooto, et al.
Scientific Reports|November 30, 2023
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degenerationRyosuke Tamiya, Masayuki Hata, Asako Tanaka, et al.
American Journal of Ophthalmology|December 1, 2023
Prevalence and Incidence of Strabismus by Age Group in Japan: A Nationwide Population-Based Cohort StudyManabu Miyata, Ai Kido, Masahiro Miyake, et al.
Communications Medicine|July 19, 2025
Lifetime risk, sex and age differences in annual incidence of ocular motor cranial nerve palsy in Japan for 2019Manabu Miyata, Ai Kido, Masahiro Miyake, et al.
Scientific Reports|June 11, 2024
Differences between pathologic and non-pathologic high myopia in 4-year outcomes of anti-VEGF therapy for macular neovascularizationYuki Honda, Manabu Miyata, Masahiro Miyake, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 9, 2021
Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims databaseAi Kido, Masahiro Miyake, Tadamichi Akagi, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 9, 2025
One-year outcomes of three-monthly and four-monthly loading regimens of faricimab for treatment-naïve neovascular age-related macular degenerationYuta Doi, Masayuki Hata, Yu Kawashima, et al.
Ophthalmology Science|October 17, 2022
Incidence and Clinical Practice of Exudative Age-related Macular Degeneration: A Nationwide Population-Based Cohort StudyAi Kido, Masahiro Miyake, Hiroshi Tamura, et al.
Ophthalmology Science|April 4, 2025
Annual Trend of Myopia and High Myopia in Children in Japan: A Nationwide Claims Database StudyTakuro Kamei, Masahiro Miyake, Ai Kido, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 26, 2024
Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular DegenerationAsako Tanaka, Masayuki Hata, Memiri Tsuchikawa, et al.
Retina (Philadelphia, Pa.)|July 25, 2023
PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGEMakoto Miki, Manabu Miyata, Sotaro Ooto, et al.
Scientific Reports|November 30, 2023
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degenerationRyosuke Tamiya, Masayuki Hata, Asako Tanaka, et al.
American Journal of Ophthalmology|December 1, 2023
Prevalence and Incidence of Strabismus by Age Group in Japan: A Nationwide Population-Based Cohort StudyManabu Miyata, Ai Kido, Masahiro Miyake, et al.
Communications Medicine|July 19, 2025
Lifetime risk, sex and age differences in annual incidence of ocular motor cranial nerve palsy in Japan for 2019Manabu Miyata, Ai Kido, Masahiro Miyake, et al.
Scientific Reports|June 11, 2024
Differences between pathologic and non-pathologic high myopia in 4-year outcomes of anti-VEGF therapy for macular neovascularizationYuki Honda, Manabu Miyata, Masahiro Miyake, et al.
Pageof 4